Net Cash Provided by (Used in) Investing Activities of Aardvark Therapeutics, Inc. from 31 Mar 2024 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Aardvark Therapeutics, Inc. quarterly Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 31 Mar 2024 to 31 Mar 2025.
  • Aardvark Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2025 was $112,624,000, a 2252380% decline year-over-year.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Change (%)

Aardvark Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $112,624,000 -$112,619,000 -2252380% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $5,000 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.